|
|
Gene Symbol |
IAPP |
|
Aliases |
DAP, IAP |
|
Entrez Gene ID |
|
|
Gene Name |
Islet amyloid polypeptide |
|
Chromosomal Location |
12p12.1 |
|
HGNC ID |
|
|
Summary |
This gene encodes a member of the calcitonin family of peptide hormones. This hormone is released from pancreatic beta cells following food intake to regulate blood glucose levels and act as a satiation signal. Human patients with type 1 and advanced type 2 diabetes exhibit reduced levels of the encoded hormone in blood and pancreas. This protein also exhibits a bactericidal, antimicrobial activity. [provided by RefSeq, Jul 2016]
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Islet amyloid polypeptide, Islet amyloid polypeptide (diabetes-associated peptide; amylin), amylin, diabetes-associated peptide, insulinoma amyloid peptide |
|
Function |
Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism |
|
|
UniProt |
|
|
PDB |
1KUW, 2G48, 2KB8, 2L86, 3DG1, 3FPO, 3FR1, 3FTH, 3FTK, 3FTL, 3FTR, 3G7V, 3G7W, 3HGZ, 5K5G, 5KNZ, 5KO0, 5MGQ |
|
Pfam |
Pfam Accession |
Pfam ID |
PF00214 |
Calc_CGRP_IAPP |
|
|
|
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Digestive System Diseases |
Gastric ulcer |
|
Endocrine System Diseases |
Diabetes Mellitus |
|
PCOS |
|
Nutritional and Metabolic Diseases |
Gluocose Intolerance |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
Preptin(IGF2) |
PCOS, chronic oligo-anovulation, clinical or biochemical hyperandrogenism, hirsutism, acne, male-type alopecia, |
|
PCOS Consensus Workshop Group, supported by the European Society for Human Reproduction and Embryology (ESHRE)/American Society for Reproductive Medicine (ASRM) |
Related
|
40 PCOS patients and 40 healthy women |
The presence of mechanisms that can prevent the elevation in serum amylin concentrations that can occur in response to the impaired glucose metabolism in PCOS patients |
|
|
|
|